The interferon-α responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma

Cancer Genetics and Cytogenetics

Volumn 177, Issue 1, 2007, Pages 6-15

  Zhou, Xiaoling ^a   Popescu, Nicholas C ^a   Klein, George ^b   Imreh, Stephan ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA INTERFERON; COMPLEMENTARY DNA; HISTONE DEACETYLASE INHIBITOR; MEMBRANE PROTEIN; MESSENGER RNA; TRANSMEMBRANE PROTEIN 7; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TMEM7 GENE; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; AZACITIDINE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, AMINO ACID;

MUS MUSCULUS;

EID: 34547669305     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.04.007     Document Type: Article

References (32)

1. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
2. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
3. Tanaka Y., Hanada K., Mizokami M., Yeo A.E., Shih J.W., Gojobori T., and Alter H.J. Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99 (2002) 15584-15589
4. Katoh H., Shibata T., Kokubu A., Ojima H., Fukayama M., Kanai Y., and Hirohasi S. Epigenetic instability and chromosomal instability in hepatocellular carcinoma. Am J Pathol 168 (2006) 1375-1384
5. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
6. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
7. Huebner K. Tumor suppressors on 3p: a neoclassic quartet. Proc Natl Acad Sci U S A 98 (2001) 14763-14765
8. Kiss H., Yang Y., Kiss C., Andersson K., Klein G., Imreh S., and Dumansky J.P. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. Eur J Hum Genet 10 (2002) 52-61
9. Imreh S., Klein G., and Zabarovsky E.R. Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38 (2003) 307-321
10. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., and Marra M.A. Mammalian Gene Collection Program Team. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 99 (2002) 16899-16903
11. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H., Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T., Baldarelli R., Hill D.P., Bult C., Hume D.A., Quackenbush J., Schriml L.M., Kanapin A., Matsuda H., Batalov S., Beisel K.W., Blake J.A., Bradt D., Brusic V., Chothia C., Corbani L.E., Cousins S., Dalla E., Dragani T.A., Fletcher C.F., Forrest A., Frazer K.S., Gaasterland T., Gariboldi M., Gissi C., Godzik A., Gough J., Grimmond S., Gustincich S., Hirokawa N., Jackson I.J., Jarvis E.D., Kanai A., Kawaji H., Kawasawa Y., Kedzierski R.M., King B.L., Konagaya A., Kurochkin I.V., Lee Y., Lenhard B., Lyons P.A., Maglott D.R., Maltais L., Marchionni L., McKenzie L., Miki H., Nagashima T., Numata K., Okido T., Pavan W.J., Pertea G., Pesole G., Petrovsky N., Pillai R., Pontius J.U., Qi D., Ramachandran S., Ravasi T., Reed J.C., Reed D.J., Reid J., Ring B.Z., Ringwald M., Sandelin A., Schneider C., Semple C.A., Setou M., Shimada K., Sultana R., Takenaka Y., Taylor M.S., Teasdale R.D., Tomita M., Verardo R., Wagner L., Wahlestedt C., Wang Y., Watanabe Y., Wells C., Wilming L.G., Wynshaw-Boris A., Yanagisawa M., Yang I., Yang L., Yuan Z., Zavolan M., Zhu Y., Zimmer A., Carninci P., Hayatsu N., Hirozane-Kishikawa T., Konno H., Nakamura M., Sakazume N., Sato K., Shiraki T., Waki K., Kawai J., Aizawa K., Arakawa T., Fukuda S., Hara A., Hashizume W., Imotani K., Ishii Y., Itoh M., Kagawa I., Miyazaki A., Sakai K., Sasaki D., Shibata K., Shinagawa A., Yasunishi A., Yoshino M., Waterston R., Lander E.S., Rogers J., Birney E., and Hayashizaki Y. FANTOM Consortium; RIKEN Genome Exploration Research Group Phase I & II Team. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420 (2002) 563-573
12. Leaman D.W., Chawla-Sarkar M., Jacobs B., Vyas K., Sun Y., Ozdemir A., Taolin Y.i., Williams B.R., and Borden E.C. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-β compared with IFN-α2. J Interferon Cytokine Res 23 (2003) 745-756
13. Zimonjic D.B., Keck C.L., Thorgeirsson S.S., and Popescu N.C. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology 29 (1999) 1208-1214
14. Pineau P., Marchio A., Nagamori S., Seki S., Tiollais P., and Dejean A. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Hepatology 37 (2003) 852-861
15. Thorgeirsson S.S. Hunting for tumor suppressor genes in liver cancer. Hepatology 37 (2003) 739-741
16. Yang B., Guo M., Herman J.G., and Clark D.P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163 (2003) 1101-1107
17. Du Y., Carling T., Fang W., Piao Z., Sheu J.C., and Huang S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 61 (2001) 8094-8099
18. Schagdarsurengin U., Wilkens L., Steinemann D., Flemming P., Kreipe H.H., Pfeifer G.P., Schlegelberger B., and Damman R. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 22 (2003) 1866-1871
19. Tischoff I., Markwarth A., Witzigmann H., Uhlmann D., Hauss J., Mirmohammadsadegh A., Wittekind C., Hengge U.R., and Tannapfel A. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 115 (2005) 684-689
20. Yu J., Ni M., Xu J., Zhang H., Gao B., Gu J., Chen J., Zhang L., Wu M., Zhen S., and Zhu J. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2 (2002) 29
21. Yuan B.Z., Keck-Waggoner C., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Alterations of FHIT gene in human hepatocellular carcinoma. Cancer Res 60 (2000) 1049-1053
22. Guan M., Zhou X., Soulitzis N., Spandidos D.A., and Popescu N.C. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res 12 (2006) 1412-1419
23. Gore S.D., Baylin S., Sugar E., Carraway H., Miller C.B., Carducci M., Grever M., Galm O., Dauses T., Karp J.E., Rudek M.A., Zhao M., Smith B.D., Manning J., Jiemjit A., Dover G., Mays A., Zwiebel J., Murgo A., Weng L.J., and Herman J.G. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res 66 (2006) 6361-6369
24. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., and Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1 (2001) 194-202
25. Zhou X., Thorgeirsson S.S., and Popescu N.C. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23 (2004) 1308-1313
26. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., Thorgeirsson S.S., and Popescu N.C. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22 (2003) 445-450
27. Yuan B.Z., Jefferson A.M., Baldwin K.T., Thorgeirsson S.S., Popescu N.C., and Reynolds S.H. DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 23 (2004) 1405-1411
28. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol 12 (2000) 419-424
29. Kaneko F., Saito H., Saito Y., Wakabayashi K., Nakamoto N., Tada S., Suzuki S., Tsunematsu S., Kumagai N., and Ishii H. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate. Int J Oncol 24 (2004) 837-845
30. Giannelli G., Bergamini C., Fransvea E., Marinosci F., Quaranta V., and Antonaci S. Human hepatocellular carcinoma (HCC) cells require both α3β1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest 81 (2001) 613-627
31. Yang Y., Li J., Szeles A., Imreh M.P., Kost-Alimova M., Kiss H., Kholodnyuk I., Fedorova L., Darai E., Imreh S., and Kein G. Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice. Cancer Lett 191 (2003) 155-164
32. Ishikado A., Imanaka H., Kotani M., Fujita A., Mitsuishi Y., Kanemitsu T., Tamura Y., and Makino T. Liposomal lactoferrin induced significant increase of the interferon-α (IFN-α) producibility in healthy volunteers. Biofactors 21 (2004) 69-72